Describing his experience, he said, Its been amazing, and added that his ultimate goal is to live longer
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for three primary indications: type 2 diabetes mellitus, chronic weight management, and cardiovascular risk reduction in adults with obesity/overweight and established cardiovascular disease
No, there is not yet an official standard maintenance dose because retatrutide remains under investigation
She is an active member of several professional societies, including the American Academy of Dermatology, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, and the Womens Dermatologic Society
Some systematic reviews and meta-analyses have suggested potential benefits for glycaemic control and modest weight reduction